Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Fontus acquires thyroid drug from Roche
Rocaltrol is a vitamin D analog prescribed by nephrologists for the management of hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure
Rocaltrol is a vitamin D analog prescribed by nephrologists for the management of hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure
Under the terms of the transaction, approved by both companies’s boards of directors, Medicis will pay stockholders upon closing $150 million in cash for all of the outstanding
Through the deal, MedAssets’s hospital customers will have access to custom group purchasing discounts as they relate to the VeinViewer, Luminetx’s signature product. Luminetx’s VeinViewer is a vascular
Delivered via intravitreal injection, the ophthalmic indications for Trivaris include sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids. These are inflammatory conditions that
The randomized, double-blind study is designed to assess the drug’s effect on dyslipidemia and insulin resistance, and will evaluate two different doses of MBX-8025 given over an eight-week
BioMedical’s Barbed OSStaple (BOSS) is an orthopedic nitinol implant with barbs on the legs for bone adhesion. Like the BioMedical Enterprises (BME) OSStaple product line, the BOSS nitinol
Eli Lilly’s Cymbalta is said to be the first serotonin-norepinephrine reuptake inhibitor with proven efficacy for reducing pain in patients with fibromyalgia. The fibromyalgia indication represents the second
Most recently, Mr Mazzocchi served as managing director of Accuitive Medical Ventures, an Atlanta-based venture capital fund that specializes in early-stage medical technology investments. Prior to that Mr
The initial results demonstrate Lofexidine’s statistical significance versus placebo in reducing withdrawal symptoms associated with opiate detoxification on the third day of treatment, which is the expected peak
Dr Freeman has been a senior medical advisor to Irx since 2007. Prior to joining Irx, Dr Freeman served as vice president of clinical development at Onyx Pharmaceutical